Hypothyroidism affects roughly 1 in 10 people in the United States. Combining both overt and subclinical cases, the overall prevalence sits at about 9.6%, based on a large retrospective analysis of national health survey and insurance claims data from 2009 to 2019. That translates to more than 20 million Americans living with some degree of thyroid underactivity, though many don’t know it.
Overt vs. Subclinical Prevalence
Not all hypothyroidism looks the same, and the numbers shift depending on which type you’re counting. About 2% of the U.S. population has overt hypothyroidism, meaning the thyroid is clearly underperforming on blood tests and often causing noticeable symptoms like fatigue, weight gain, and cold sensitivity. When you include people already taking thyroid medication (who would test as hypothyroid without it), that figure climbs to around 6%.
Subclinical hypothyroidism is milder. Your thyroid hormone levels still fall within the normal range, but your brain is already working harder to keep them there, pumping out extra thyroid-stimulating hormone (TSH). Roughly 1% to 10% of the population falls into this category depending on the study and the TSH cutoff used. In the U.S., national survey data puts untreated subclinical hypothyroidism at about 1% to 1.4% of the population. Many people in this group have no symptoms at all and are only identified through routine blood work.
Why Women Are Far More Likely to Be Affected
Hypothyroidism is overwhelmingly more common in women. The ratio is at least 4 to 1 compared to men, and some studies put it higher. In one large population-based study, 10% of women had thyroid dysfunction compared to 2.9% of men. The gap is especially pronounced in premenopausal women, likely because estrogen and the immune system interact in ways that make autoimmune thyroid disease more probable in females.
Pregnancy adds another layer of risk. About 1 in 25 women develops postpartum thyroiditis, an inflammation of the thyroid gland that typically strikes within the first year after delivery. Of those women, roughly 82% go through a hypothyroid phase. For some, it resolves on its own within months. For others, it becomes permanent.
How Age Changes the Numbers
Hypothyroidism becomes significantly more common as you get older. A screening study of more than 25,000 people found that among those aged 65 to 74, about 10% of men and 16% of women had elevated TSH levels. In people 75 and older, those numbers rose to 16% of men and 21% of women.
Even in people over 80 who show no signs of autoimmune thyroid disease, 12% still have elevated TSH. This raises an interesting question researchers continue to grapple with: is a mildly elevated TSH in an 80-year-old truly a problem, or does the body’s “normal” TSH range naturally drift upward with age? For now, treatment decisions in older adults tend to be more conservative, focusing on whether symptoms are present rather than chasing a number on a lab report.
Differences Across Race and Ethnicity
In adolescents, national data shows hypothyroidism rates of 1.9% among non-Hispanic White teens, 0.9% among Mexican American teens, and 0.7% among non-Hispanic Black teens. While those numbers suggest some variation, the differences were not statistically significant in the analysis. The pattern seen in adults is similar: White populations tend to have slightly higher reported rates of hypothyroidism, but genetics, access to screening, and dietary iodine intake all complicate direct comparisons.
What Causes It
Globally, the single biggest driver of hypothyroidism is not getting enough iodine in your diet. Your thyroid needs iodine to manufacture its hormones, and in parts of Europe, Africa, and Asia where iodine intake is still low, deficiency remains a major cause of thyroid failure. In countries like the United States, where table salt has been iodized since the 1920s, iodine deficiency is rare.
In iodine-sufficient countries, the leading cause is Hashimoto’s thyroiditis, an autoimmune condition where the immune system gradually attacks the thyroid gland. Over months or years, this damage reduces the gland’s ability to produce hormones. The relationship between iodine and thyroid disease follows a U-shaped curve: too little iodine causes problems, but very high iodine intake can also trigger autoimmune thyroid disease. A Danish study of older adults illustrated this clearly. In an iodine-deficient town, 6% of residents were hypothyroid. In an iodine-sufficient town nearby, 13% were hypothyroid, though they had far lower rates of goiter and hyperthyroidism.
Other common causes include surgical removal of the thyroid (often for cancer or nodules), radioactive iodine treatment for an overactive thyroid, certain medications, and radiation therapy to the head or neck.
How Many Cases Go Undiagnosed
A significant portion of hypothyroidism flies under the radar. Because symptoms like fatigue, dry skin, constipation, and brain fog overlap with dozens of other conditions (or just the experience of being busy and stressed), many people never connect the dots. Subclinical cases, by definition, produce few or no obvious symptoms, making them especially easy to miss without a blood test.
Prevalence estimates also vary widely from study to study because researchers use different TSH cutoffs, study different age groups, and define the condition in slightly different ways. Using a TSH threshold of 4.0 versus 4.5 can shift the numbers meaningfully. This inconsistency means the true burden of hypothyroidism in the population is probably higher than any single estimate captures, particularly among older women who may attribute their symptoms to aging rather than a treatable thyroid condition.
What Gets Tested and What the Numbers Mean
Hypothyroidism is diagnosed with a simple blood test measuring TSH. A normal TSH generally falls between about 0.5 and 4.5 mIU/L. When TSH climbs above that range but thyroid hormone levels remain normal, the diagnosis is subclinical hypothyroidism. When TSH is elevated and thyroid hormone levels drop below normal, it’s overt hypothyroidism.
Some providers further classify subclinical cases by severity: grade 1 when TSH is between 4.5 and 9.9, and grade 2 when TSH reaches 10 or higher. Grade 2 subclinical hypothyroidism is more likely to progress to overt disease and more likely to benefit from treatment. Grade 1, particularly in older adults, is often monitored with repeat testing rather than treated immediately, since TSH can fluctuate on its own and may return to normal without intervention.